FDA Inspection
Oxford Pharmaceuticals, LLCOxford Pharmaceuticals, LLC – FDA Inspection, Sep 2, 2026
Record Details
This FDA Inspection record concerns Oxford Pharmaceuticals, LLC, with an inspection on September 2, 2026, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 4e4530db-12c1-4327-b044-4ed5c783ab5a
Inspection Facts
- Inspection number
- 1334078
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- FDCA 582(e)(4)Systems in place to comply with verification requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Oxford Pharmaceuticals, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 3, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 8, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Oxford Pharmaceuticals, LLC
- FDA Inspection 1221787 - 2023-11-03
- FDA Inspection 1174389 - 2022-06-08
- FDA Inspection 1092451 - 2019-05-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.